Literature DB >> 8474729

General practitioners acceptance of the validity of chronic fatigue syndrome as a diagnosis.

H Denz-Penhey1, J C Murdoch.   

Abstract

AIM: To identify whether general practitioners accept the validity of a diagnosis of chronic fatigue syndrome (CFS).
METHOD: An anonymous questionnaire was sent out to 98 general practitioners in Otago.
RESULTS: The clinical validity of chronic fatigue syndrome was accepted by 74 (90%); 57 believed they had sufficient knowledge about the condition to make a differential diagnosis; 72 indicated they had had patients with chronic fatigue syndrome in the past; 62 currently had patients; there is a minimum prevalence rate of 167/100,000 in the general practice population; 83 replies were received.
CONCLUSION: The 90% acceptance rate of chronic fatigue syndrome as a clinically valid diagnosis suggests that amongst the Otago general practitioners the controversy had receded. The low numbers suggest that they are on the conservative end of the diagnostic spectrum.

Entities:  

Mesh:

Year:  1993        PMID: 8474729

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  3 in total

1.  GPs' attitudes to a self diagnosis of myalgic encephalomyelitis. Sufferers continue to be misrepresented.

Authors:  M Arber
Journal:  BMJ       Date:  1995-05-20

2.  Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome.

Authors:  Tricia Pendergrast; Abigail Brown; Madison Sunnquist; Rachel Jantke; Julia L Newton; Elin Bolle Strand; Leonard A Jason
Journal:  Chronic Illn       Date:  2016-04-28

3.  Social support needs for equity in health and social care: a thematic analysis of experiences of people with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jose C de Carvalho Leite; Maria de L Drachler; Anne Killett; Swati Kale; Luis Nacul; Maggie McArthur; Chia Swee Hong; Lucy O'Driscoll; Derek Pheby; Peter Campion; Eliana Lacerda; Fiona Poland
Journal:  Int J Equity Health       Date:  2011-11-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.